Steve Valiquette
Stock Analyst at Barclays
(1.83)
# 3,247
Out of 4,967 analysts
158
Total ratings
45.45%
Success rate
-3.73%
Average return
Main Sectors:
Stocks Rated by Steve Valiquette
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BKD Brookdale Senior Living | Maintains: Equal-Weight | $7.5 → $8 | $7.69 | +4.03% | 5 | Aug 7, 2025 | |
| TDOC Teladoc Health | Maintains: Overweight | $10 → $12 | $7.49 | +60.21% | 13 | Oct 31, 2024 | |
| MCK McKesson | Maintains: Overweight | $596 → $616 | $693.54 | -11.18% | 6 | Aug 8, 2024 | |
| GDRX GoodRx Holdings | Maintains: Overweight | $8 → $9 | $4.26 | +111.52% | 7 | Mar 1, 2024 | |
| HOUS Anywhere Real Estate | Maintains: Underweight | $4.5 → $5 | $5.94 | -15.75% | 3 | Feb 20, 2024 | |
| MPW Medical Properties Trust | Maintains: Overweight | $12 → $10 | $4.37 | +129.10% | 5 | Aug 22, 2023 | |
| HR Healthcare Realty Trust | Maintains: Equal-Weight | $25 → $24 | $17.26 | +39.09% | 4 | Aug 11, 2023 | |
| CVS CVS Health | Maintains: Overweight | $89 → $86 | $74.07 | +16.11% | 14 | Aug 3, 2023 | |
| CNC Centene | Maintains: Overweight | $86 → $85 | $29.62 | +186.97% | 6 | Jul 31, 2023 | |
| HCA HCA Healthcare | Maintains: Equal-Weight | $275 → $300 | $406.73 | -26.24% | 4 | Jun 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $35 → $34 | $36.44 | -6.70% | 3 | May 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $70 → $105 | $184.87 | -43.20% | 3 | Apr 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $57 → $55 | $67.75 | -18.82% | 3 | Apr 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $15 → $13 | $19.20 | -32.29% | 11 | Apr 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Equal-Weight | $132 → $142 | $181.59 | -21.80% | 2 | Apr 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $13 → $5 | $25.76 | -80.59% | 4 | Apr 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Equal-Weight | $57 | $122.91 | -53.62% | 2 | Mar 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $78 → $82 | $167.96 | -51.18% | 5 | Jan 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $20 → $18 | $17.90 | +0.59% | 2 | Jan 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $33 → $31 | $42.59 | -27.21% | 2 | Jan 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $400 → $375 | $183.84 | +103.98% | 3 | Jan 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $20 → $19 | $34.37 | -44.72% | 2 | Oct 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $500 → $570 | $312.21 | +82.57% | 4 | Jul 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Equal-Weight | $70 → $64 | $149.84 | -57.29% | 4 | May 26, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $275 → $310 | $302.74 | +2.40% | 16 | May 23, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $495 → $565 | $310.17 | +82.16% | 3 | Mar 30, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Equal-Weight | $150 → $75 | $5.01 | +1,397.63% | 4 | Nov 10, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $26 → $19 | $3.83 | +396.08% | 2 | Aug 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $6 → $10 | $2.79 | +259.07% | 10 | Aug 3, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underweight | $42 → $34 | $25.90 | +31.27% | 4 | May 28, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $20 | $8.20 | +144.05% | 1 | May 24, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reinstates: Overweight | $260 | $108.67 | +139.26% | 1 | Feb 19, 2021 |
Brookdale Senior Living
Aug 7, 2025
Maintains: Equal-Weight
Price Target: $7.5 → $8
Current: $7.69
Upside: +4.03%
Teladoc Health
Oct 31, 2024
Maintains: Overweight
Price Target: $10 → $12
Current: $7.49
Upside: +60.21%
McKesson
Aug 8, 2024
Maintains: Overweight
Price Target: $596 → $616
Current: $693.54
Upside: -11.18%
GoodRx Holdings
Mar 1, 2024
Maintains: Overweight
Price Target: $8 → $9
Current: $4.26
Upside: +111.52%
Anywhere Real Estate
Feb 20, 2024
Maintains: Underweight
Price Target: $4.5 → $5
Current: $5.94
Upside: -15.75%
Medical Properties Trust
Aug 22, 2023
Maintains: Overweight
Price Target: $12 → $10
Current: $4.37
Upside: +129.10%
Healthcare Realty Trust
Aug 11, 2023
Maintains: Equal-Weight
Price Target: $25 → $24
Current: $17.26
Upside: +39.09%
CVS Health
Aug 3, 2023
Maintains: Overweight
Price Target: $89 → $86
Current: $74.07
Upside: +16.11%
Centene
Jul 31, 2023
Maintains: Overweight
Price Target: $86 → $85
Current: $29.62
Upside: +186.97%
HCA Healthcare
Jun 28, 2023
Maintains: Equal-Weight
Price Target: $275 → $300
Current: $406.73
Upside: -26.24%
May 3, 2023
Maintains: Underweight
Price Target: $35 → $34
Current: $36.44
Upside: -6.70%
Apr 26, 2023
Maintains: Overweight
Price Target: $70 → $105
Current: $184.87
Upside: -43.20%
Apr 25, 2023
Maintains: Overweight
Price Target: $57 → $55
Current: $67.75
Upside: -18.82%
Apr 25, 2023
Maintains: Equal-Weight
Price Target: $15 → $13
Current: $19.20
Upside: -32.29%
Apr 25, 2023
Upgrades: Equal-Weight
Price Target: $132 → $142
Current: $181.59
Upside: -21.80%
Apr 5, 2023
Maintains: Underweight
Price Target: $13 → $5
Current: $25.76
Upside: -80.59%
Mar 14, 2023
Initiates: Equal-Weight
Price Target: $57
Current: $122.91
Upside: -53.62%
Jan 17, 2023
Maintains: Overweight
Price Target: $78 → $82
Current: $167.96
Upside: -51.18%
Jan 17, 2023
Maintains: Overweight
Price Target: $20 → $18
Current: $17.90
Upside: +0.59%
Jan 17, 2023
Maintains: Equal-Weight
Price Target: $33 → $31
Current: $42.59
Upside: -27.21%
Jan 4, 2023
Maintains: Overweight
Price Target: $400 → $375
Current: $183.84
Upside: +103.98%
Oct 21, 2022
Maintains: Equal-Weight
Price Target: $20 → $19
Current: $34.37
Upside: -44.72%
Jul 28, 2022
Maintains: Overweight
Price Target: $500 → $570
Current: $312.21
Upside: +82.57%
May 26, 2022
Downgrades: Equal-Weight
Price Target: $70 → $64
Current: $149.84
Upside: -57.29%
May 23, 2022
Maintains: Overweight
Price Target: $275 → $310
Current: $302.74
Upside: +2.40%
Mar 30, 2022
Maintains: Overweight
Price Target: $495 → $565
Current: $310.17
Upside: +82.16%
Nov 10, 2021
Downgrades: Equal-Weight
Price Target: $150 → $75
Current: $5.01
Upside: +1,397.63%
Aug 12, 2021
Upgrades: Overweight
Price Target: $26 → $19
Current: $3.83
Upside: +396.08%
Aug 3, 2021
Maintains: Underweight
Price Target: $6 → $10
Current: $2.79
Upside: +259.07%
May 28, 2021
Downgrades: Underweight
Price Target: $42 → $34
Current: $25.90
Upside: +31.27%
May 24, 2021
Initiates: Overweight
Price Target: $20
Current: $8.20
Upside: +144.05%
Feb 19, 2021
Reinstates: Overweight
Price Target: $260
Current: $108.67
Upside: +139.26%